Compile Data Set for Download or QSAR
Found 34 Enz. Inhib. hit(s) with all data for entry = 50031520
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314676((4-(6-fluoroquinazolin-2-yl)-1,4-diazepan-1-yl)(5-...)copy SMILEScopy InChI
Affinity DataKi:  0.200nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314681((5-chloro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(6-fl...)copy SMILEScopy InChI
Affinity DataKi:  0.400nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314681((5-chloro-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(6-fl...)copy SMILEScopy InChI
Affinity DataKi:  0.600nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50258741((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(4-(quin...)copy SMILEScopy InChI
Affinity DataKi:  0.600nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314676((4-(6-fluoroquinazolin-2-yl)-1,4-diazepan-1-yl)(5-...)copy SMILEScopy InChI
Affinity DataKi:  1nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50258741((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(4-(quin...)copy SMILEScopy InChI
Affinity DataKi:  1.20nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  2.30nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  2.30nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  3.60nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  3.60nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314678((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(3-(quin...)copy SMILEScopy InChI
Affinity DataKi:  11nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314678((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(3-(quin...)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  110nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataKi:  155nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314679((6-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataKi:  260nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314679((6-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataKi:  870nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314680((2-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataKi:  1.70E+3nMAssay Description:Binding affinity to OX1 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314680((2-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataKi:  3.50E+3nMAssay Description:Binding affinity to OX2 receptor by radioligand displacement assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314676((4-(6-fluoroquinazolin-2-yl)-1,4-diazepan-1-yl)(5-...)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50258741((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(4-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50258741((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(4-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 29nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314676((4-(6-fluoroquinazolin-2-yl)-1,4-diazepan-1-yl)(5-...)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 42nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 65nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 65nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314678((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(3-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 77nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314678((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(3-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 110nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 2.50E+3nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314680((2-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataIC50: 3.70E+3nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314680((2-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataIC50: 3.90E+3nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin/Hypocretin receptor type 1(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314679((6-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataIC50: 5.70E+3nMAssay Description:Antagonist activity at OX1 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314677((5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)(6-(quin...)copy SMILEScopy InChI
Affinity DataIC50: 6.20E+3nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed
TargetOrexin receptor type 2(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50314679((6-(6-fluoroquinazolin-2-yl)-2,6-diazabicyclo[3.2....)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2MK6D26PubMed